AU691490B2 - Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans - Google Patents

Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans Download PDF

Info

Publication number
AU691490B2
AU691490B2 AU62679/94A AU6267994A AU691490B2 AU 691490 B2 AU691490 B2 AU 691490B2 AU 62679/94 A AU62679/94 A AU 62679/94A AU 6267994 A AU6267994 A AU 6267994A AU 691490 B2 AU691490 B2 AU 691490B2
Authority
AU
Australia
Prior art keywords
international
formula
methoxy
document
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62679/94A
Other languages
English (en)
Other versions
AU6267994A (en
Inventor
Peter Buontempo
Stuart A Cox
Jason L Demartino
John F O'connell
Edward J Rozhon
Jacquelyn M Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU6267994A publication Critical patent/AU6267994A/en
Application granted granted Critical
Publication of AU691490B2 publication Critical patent/AU691490B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
AU62679/94A 1993-02-26 1994-02-23 Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans Ceased AU691490B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2352793A 1993-02-26 1993-02-26
US023527 1993-02-26
PCT/US1994/001605 WO1994018960A1 (en) 1993-02-26 1994-02-23 Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans

Publications (2)

Publication Number Publication Date
AU6267994A AU6267994A (en) 1994-09-14
AU691490B2 true AU691490B2 (en) 1998-05-21

Family

ID=21815649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62679/94A Ceased AU691490B2 (en) 1993-02-26 1994-02-23 Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans

Country Status (12)

Country Link
EP (1) EP0686032A1 (cs)
JP (1) JPH08507062A (cs)
AU (1) AU691490B2 (cs)
CA (1) CA2156916A1 (cs)
FI (1) FI953980L (cs)
HU (1) HUT72490A (cs)
IL (1) IL108749A0 (cs)
MX (1) MXPA94001379A (cs)
NZ (1) NZ262794A (cs)
TW (1) TW284686B (cs)
WO (1) WO1994018960A1 (cs)
ZA (1) ZA941244B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020070390A1 (en) 2018-10-03 2020-04-09 Jyväskylän Yliopisto Vemurafenib and salts thereof for use in the treatment of enteroviral infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159702A2 (de) * 1984-04-26 1985-10-30 William Prym GmbH & Co. KG Selbstbedienungs-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung für Fadenlege-Werkzeuge, wie Stricknadeln
WO1992022520A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159702A2 (de) * 1984-04-26 1985-10-30 William Prym GmbH & Co. KG Selbstbedienungs-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung für Fadenlege-Werkzeuge, wie Stricknadeln
WO1992022520A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds

Also Published As

Publication number Publication date
FI953980A7 (fi) 1995-08-24
CA2156916A1 (en) 1994-09-01
MXPA94001379A (es) 2011-09-26
AU6267994A (en) 1994-09-14
NZ262794A (en) 1997-03-24
HUT72490A (en) 1996-05-28
IL108749A0 (en) 1994-05-30
WO1994018960A1 (en) 1994-09-01
TW284686B (cs) 1996-09-01
EP0686032A1 (en) 1995-12-13
ZA941244B (en) 1994-08-23
FI953980A0 (fi) 1995-08-24
JPH08507062A (ja) 1996-07-30
FI953980L (fi) 1995-08-24
HU9502494D0 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
Tufan et al. COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs
Woods et al. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug
McKinlay et al. Oral efficacy of WIN 51711 in mice infected with human poliovirus
UA121376C2 (uk) Інгібітори реплікації вірусів грипу
CA3166282A1 (en) Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia
US20240390316A1 (en) Use of doxepin hydrochloride in preparation of antiviral drug
AU691490B2 (en) Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans
Fu et al. Comparison of the different medications for COVID-19 in kidney transplant recipients
CA1147752A (en) Isoprenylamines
CN102335171A (zh) 一类n-(2-噻唑)苯甲酰胺衍生物的应用
US11369612B2 (en) Treatment of RSV with combination product
Togo et al. Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection
US4303658A (en) Antiviral pyrazolopyrazines
JPS63264527A (ja) 抗エイズウイルス剤
CN103070876B (zh) 一类抗乙型脑炎病毒感染的组合物及其应用
RU2824607C2 (ru) 2-(имидазол-4-ил)-этанамид пентандиовой-1,5 кислоты или его фармацевтически приемлемая соль для лечения covid-19 и ее симптомов
CN113082028B (zh) Alpelisib化合物在制备抗EV71病毒药物中的应用
CN113440562B (zh) 复方鱼腥草合剂在制备预防或治疗冠状病毒药物中的应用
CN113546067B (zh) 具有抗病毒作用的蒽醌衍生物
Jayanti et al. Leucocytoclastic vasculitis in infant
CN118831089A (zh) 土贝母皂苷甲在制备调节性t细胞分化抑制剂中的应用
JPH03167125A (ja) 抗水痘―帯状疱疹ウイルス剤
CN120131604A (zh) 拉伯醇在制备防治猫杯状病毒感染药物中的应用
Bean Antiviral therapy: New drugs and their uses
Ghimire et al. HAND, FOOT AND MOUTH DISEASE